BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Huang ML, Shen GT, Li NL. Emerging potential of ubiquitin-specific proteases and ubiquitin-specific proteases inhibitors in breast cancer treatment. World J Clin Cases 2022; 10(32): 11690-11701 [PMID: 36405275 DOI: 10.12998/wjcc.v10.i32.11690]
URL: https://www.wjgnet.com/2307-8960/full/v10/i32/11690.htm
Number Citing Articles
1
Xiaohan Wang, Sisi Wei, Wanzhao Li, Xiaojian Wei, Cong Zhang, Suli Dai, Ming Ma, Lianmei Zhao, Baoen Shan. P-Hydroxylcinnamaldehyde induces tumor-associated macrophage polarization toward the M1 type by regulating the proteome and inhibits ESCC in vivo and in vitroInternational Immunopharmacology 2023; 119: 110213 doi: 10.1016/j.intimp.2023.110213
2
Danielle Whitham, Pathea Bruno, Norman Haaker, Kathleen F. Arcaro, Brian T. Pentecost, Costel C. Darie. Deciphering a proteomic signature for the early detection of breast cancer from breast milk: the role of quantitative proteomicsExpert Review of Proteomics 2024; 21(1-3): 81 doi: 10.1080/14789450.2024.2320158
3
Lili Kong, Xiaofeng Jin. Dysregulation of deubiquitination in breast cancerGene 2024; 902: 148175 doi: 10.1016/j.gene.2024.148175